Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say – Reuters

  1. Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say  Reuters
  2. A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults  Nature
  3. Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance  Medical Xpress
  4. Weight loss jabs Mounjaro and Wegovy are so effective they should be the first treatment for obesity ‘in almost all cases’, new guidance says  Daily Mail
  5. Mounjaro and Wegovy should be first option to treat heart failure, say doctors  The i Paper

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *